Showing results (201-210 of 222) with videos related to
Sort By:
Pageof 23
Pediatric Surgery International|September 28, 2010
Oxidative stress after living related liver transplantation subsides with time in pediatric patientsMohamed Hamed Hussein, Takashi Hashimoto, Ghada Abdel-Hamid Daoud, et al.Pediatric Research|October 9, 2012
Endothelin receptor antagonist attenuates oxidative stress in a neonatal sepsis piglet modelTatenobu Goto, Mohamed Hamed Hussein, Shin Kato, et al.Annals of Transplantation|June 25, 2013
Children undergoing liver transplantation for treatment of inherited metabolic diseases are prone to higher oxidative stress, complement activity and transforming growth factor-β1Mohamed Hamed Hussein, Takashi Hashimoto, Tatsuya Suzuki, et al.Plos One|May 17, 2017
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance resultsNorio Hanafusa, Ayako Isoai, Tomoaki Ishihara, et al.Orphanet Journal of Rare Diseases|July 24, 2025
Japanese experience of newborn screening for lysosomal storage diseases and adrenoleukodystrophyTakanori Onuki, Makiko Tajika, Yohei Sugiyama, et al.International Journal of Clinical Oncology|October 18, 2023
Usefulness of genotyping APC gene for individualizing management of patients with familial adenomatous polyposisYoshiko Mori, Hideyuki Ishida, Noriyasu Chika, et al.Blood|September 24, 2008
HapMap scanning of novel human minor histocompatibility antigensMichi Kamei, Yasuhito Nannya, Hiroki Torikai, et al.Journal of Clinical Immunology|July 28, 2022
TREC/KREC Newborn Screening followed by Next-Generation Sequencing for Severe Combined Immunodeficiency in JapanManabu Wakamatsu, Daiei Kojima, Hideki Muramatsu, et al.Journal of Inherited Metabolic Disease|February 15, 2014
Clinical, biochemical and molecular analysis of 13 Japanese patients with β-ureidopropionase deficiency demonstrates high prevalence of the c.977G > A (p.R326Q) mutation [corrected]Yoko Nakajima, Judith Meijer, Doreen Dobritzsch, et al.Plos One|July 17, 2026
A phase III double-blind, placebo-controlled, randomized withdrawal trial of 5‑aminolevulinic acid hydrochloride with sodium ferrous citrate for efficacy and safety in patients diagnosed as Leigh syndromeAkira Ohtake, Yuichi Abe, Kei Murayama, et al.Pageof 23